ReShape Lifesciences (RSLS) announced that it has signed an agreement with Haifa, Israel-based Motion Informatics to exclusively import and distribute their next-generation neuromuscular rehabilitation devices in the U.S. The flagship product, the Stimel-03, was showcased at the American Occupational Therapy Association 2025 Annual Conference and Expo, held April 3-5 in Philadelphia, Pennsylvania.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RSLS:
- ReShape Lifesciences Delays Yearly Report Filing
- ReShape Lifesciences Faces Board Resignation Challenge
- ReShape receives notice of allowance for patent related to Neuromodulation
- ReShape Lifesciences signs distribution agreement with Liaison Medical
- ReShape Lifesciences Announces Securities Purchase Agreement
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue